Focal versus diffuse anaplasia in Wilms tumor - New definitions with prognostic significance: A report from the National Wilms Tumor Study Group

Paulo Faria, J. Bruce Beckwith, Kiran Mishra, Craig Zuppan, Douglas Weeks, Norman Breslow, Daniel M. Green

Research output: Contribution to journalArticle

138 Citations (Scopus)

Abstract

Anaplasia, defined by the presence of extreme nuclear and mitotic atypia, is a potent marker of adverse prognosis in Wilms tumor (WT). Anaplastic WT cells apparently have increased resistance to therapy rather than increased aggressiveness. The distribution of anaplasia should therefore have critical prognostic relevance. The original definitions for focal anaplasia (FA) and diffuse anaplasia (DA) were based on quantitative rather than topographical criteria and lacked prognostic significance. A new definition was developed based on the distribution of anaplastic changes within the tumor: FA applies only to tumors with anaplasia confined to one or a few discrete loci within the primary tumor, with no anaplasia or marked nuclear atypia elsewhere. This revised definition was evaluated in 165 cases with anaplastic WT entered on the third and fourth National Wilms Tumor Study. Only three relapses and one death occurred among 39 cases with FA, regardless of tumor stage, a result comparable to that for nonanaplastic WT. Eight children with metastases at diagnosis and FA in the primary tumor were alive and free of relapse; 22 of 23 children with stage IV DA WT died of tumor. This new definition reinforces the importance of carefully documenting the exact site from which each tumor section is obtained.

Original languageEnglish (US)
Pages (from-to)909-920
Number of pages12
JournalAmerican Journal of Surgical Pathology
Volume20
Issue number8
DOIs
StatePublished - Aug 1996
Externally publishedYes

Fingerprint

Anaplasia
Wilms Tumor
Neoplasms
Recurrence

Keywords

  • Anaplasia
  • Nephroblastoma
  • Ploidy
  • Prognostic marker
  • Resistance marker
  • Tumor stage
  • Wilms tumor

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine

Cite this

Focal versus diffuse anaplasia in Wilms tumor - New definitions with prognostic significance : A report from the National Wilms Tumor Study Group. / Faria, Paulo; Beckwith, J. Bruce; Mishra, Kiran; Zuppan, Craig; Weeks, Douglas; Breslow, Norman; Green, Daniel M.

In: American Journal of Surgical Pathology, Vol. 20, No. 8, 08.1996, p. 909-920.

Research output: Contribution to journalArticle

Faria, Paulo ; Beckwith, J. Bruce ; Mishra, Kiran ; Zuppan, Craig ; Weeks, Douglas ; Breslow, Norman ; Green, Daniel M. / Focal versus diffuse anaplasia in Wilms tumor - New definitions with prognostic significance : A report from the National Wilms Tumor Study Group. In: American Journal of Surgical Pathology. 1996 ; Vol. 20, No. 8. pp. 909-920.
@article{093fe0f92f31471b9cd73b505af3eed3,
title = "Focal versus diffuse anaplasia in Wilms tumor - New definitions with prognostic significance: A report from the National Wilms Tumor Study Group",
abstract = "Anaplasia, defined by the presence of extreme nuclear and mitotic atypia, is a potent marker of adverse prognosis in Wilms tumor (WT). Anaplastic WT cells apparently have increased resistance to therapy rather than increased aggressiveness. The distribution of anaplasia should therefore have critical prognostic relevance. The original definitions for focal anaplasia (FA) and diffuse anaplasia (DA) were based on quantitative rather than topographical criteria and lacked prognostic significance. A new definition was developed based on the distribution of anaplastic changes within the tumor: FA applies only to tumors with anaplasia confined to one or a few discrete loci within the primary tumor, with no anaplasia or marked nuclear atypia elsewhere. This revised definition was evaluated in 165 cases with anaplastic WT entered on the third and fourth National Wilms Tumor Study. Only three relapses and one death occurred among 39 cases with FA, regardless of tumor stage, a result comparable to that for nonanaplastic WT. Eight children with metastases at diagnosis and FA in the primary tumor were alive and free of relapse; 22 of 23 children with stage IV DA WT died of tumor. This new definition reinforces the importance of carefully documenting the exact site from which each tumor section is obtained.",
keywords = "Anaplasia, Nephroblastoma, Ploidy, Prognostic marker, Resistance marker, Tumor stage, Wilms tumor",
author = "Paulo Faria and Beckwith, {J. Bruce} and Kiran Mishra and Craig Zuppan and Douglas Weeks and Norman Breslow and Green, {Daniel M.}",
year = "1996",
month = "8",
doi = "10.1097/00000478-199608000-00001",
language = "English (US)",
volume = "20",
pages = "909--920",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Focal versus diffuse anaplasia in Wilms tumor - New definitions with prognostic significance

T2 - A report from the National Wilms Tumor Study Group

AU - Faria, Paulo

AU - Beckwith, J. Bruce

AU - Mishra, Kiran

AU - Zuppan, Craig

AU - Weeks, Douglas

AU - Breslow, Norman

AU - Green, Daniel M.

PY - 1996/8

Y1 - 1996/8

N2 - Anaplasia, defined by the presence of extreme nuclear and mitotic atypia, is a potent marker of adverse prognosis in Wilms tumor (WT). Anaplastic WT cells apparently have increased resistance to therapy rather than increased aggressiveness. The distribution of anaplasia should therefore have critical prognostic relevance. The original definitions for focal anaplasia (FA) and diffuse anaplasia (DA) were based on quantitative rather than topographical criteria and lacked prognostic significance. A new definition was developed based on the distribution of anaplastic changes within the tumor: FA applies only to tumors with anaplasia confined to one or a few discrete loci within the primary tumor, with no anaplasia or marked nuclear atypia elsewhere. This revised definition was evaluated in 165 cases with anaplastic WT entered on the third and fourth National Wilms Tumor Study. Only three relapses and one death occurred among 39 cases with FA, regardless of tumor stage, a result comparable to that for nonanaplastic WT. Eight children with metastases at diagnosis and FA in the primary tumor were alive and free of relapse; 22 of 23 children with stage IV DA WT died of tumor. This new definition reinforces the importance of carefully documenting the exact site from which each tumor section is obtained.

AB - Anaplasia, defined by the presence of extreme nuclear and mitotic atypia, is a potent marker of adverse prognosis in Wilms tumor (WT). Anaplastic WT cells apparently have increased resistance to therapy rather than increased aggressiveness. The distribution of anaplasia should therefore have critical prognostic relevance. The original definitions for focal anaplasia (FA) and diffuse anaplasia (DA) were based on quantitative rather than topographical criteria and lacked prognostic significance. A new definition was developed based on the distribution of anaplastic changes within the tumor: FA applies only to tumors with anaplasia confined to one or a few discrete loci within the primary tumor, with no anaplasia or marked nuclear atypia elsewhere. This revised definition was evaluated in 165 cases with anaplastic WT entered on the third and fourth National Wilms Tumor Study. Only three relapses and one death occurred among 39 cases with FA, regardless of tumor stage, a result comparable to that for nonanaplastic WT. Eight children with metastases at diagnosis and FA in the primary tumor were alive and free of relapse; 22 of 23 children with stage IV DA WT died of tumor. This new definition reinforces the importance of carefully documenting the exact site from which each tumor section is obtained.

KW - Anaplasia

KW - Nephroblastoma

KW - Ploidy

KW - Prognostic marker

KW - Resistance marker

KW - Tumor stage

KW - Wilms tumor

UR - http://www.scopus.com/inward/record.url?scp=0029904405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029904405&partnerID=8YFLogxK

U2 - 10.1097/00000478-199608000-00001

DO - 10.1097/00000478-199608000-00001

M3 - Article

C2 - 8712292

AN - SCOPUS:0029904405

VL - 20

SP - 909

EP - 920

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 8

ER -